Literature DB >> 24048132

IL-1 signaling in atherosclerosis: sibling rivalry.

Frederick J Sheedy1, Kathryn J Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24048132     DOI： 10.1038/ni.2711

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  15 in total

1.  Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism.

Authors:  Yehuda Kamari; Rachel Werman-Venkert; Aviv Shaish; Ariel Werman; Ayelet Harari; Ayelet Gonen; Elena Voronov; Itamar Grosskopf; Yehonatan Sharabi; Ehud Grossman; Yoichiro Iwakura; Charles A Dinarello; Ron N Apte; Dror Harats
Journal:  Atherosclerosis       Date:  2006-12-14       Impact factor: 5.162

Review 2.  The immune system in atherosclerosis.

Authors:  Göran K Hansson; Andreas Hermansson
Journal:  Nat Immunol       Date:  2011-03       Impact factor: 25.606

3.  Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.

Authors:  Stefan Freigang; Franziska Ampenberger; Gunther Spohn; Sebastian Heer; Abdijapar T Shamshiev; Jan Kisielow; Martin Hersberger; Masayuki Yamamoto; Martin F Bachmann; Manfred Kopf
Journal:  Eur J Immunol       Date:  2011-06-08       Impact factor: 5.532

4.  Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice.

Authors:  Matthew R Alexander; Christopher W Moehle; Jason L Johnson; Zhengyu Yang; Jae K Lee; Christopher L Jackson; Gary K Owens
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

5.  Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.

Authors:  Vinay Bhaskar; Johnny Yin; Amer M Mirza; Dan Phan; Sandra Vanegas; Hassan Issafras; Kristen Michelson; John J Hunter; Seema S Kantak
Journal:  Atherosclerosis       Date:  2011-02-24       Impact factor: 5.162

6.  Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α.

Authors:  Yehuda Kamari; Aviv Shaish; Shay Shemesh; Einav Vax; Itamar Grosskopf; Shahar Dotan; Malka White; Elena Voronov; Charles A Dinarello; Ron N Apte; Dror Harats
Journal:  Biochem Biophys Res Commun       Date:  2011-01-08       Impact factor: 3.575

Review 7.  Regulation of interleukin 1α secretion by inflammasomes.

Authors:  Amir S Yazdi; Stefan K Drexler
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

Review 8.  Effect of interleukin 1β inhibition in cardiovascular disease.

Authors:  Arman Qamar; Daniel J Rader
Journal:  Curr Opin Lipidol       Date:  2012-12       Impact factor: 4.776

9.  Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.

Authors:  Stefan Freigang; Franziska Ampenberger; Adrienne Weiss; Thirumala-Devi Kanneganti; Yoichiro Iwakura; Martin Hersberger; Manfred Kopf
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

10.  Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.

Authors:  P Menu; M Pellegrin; J-F Aubert; K Bouzourene; A Tardivel; L Mazzolai; J Tschopp
Journal:  Cell Death Dis       Date:  2011-03-31       Impact factor: 8.469
View more
  25 in total

1.  Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner.

Authors:  Stephanie A Conos; Kaiwen W Chen; Dominic De Nardo; Hideki Hara; Lachlan Whitehead; Gabriel Núñez; Seth L Masters; James M Murphy; Kate Schroder; David L Vaux; Kate E Lawlor; Lisa M Lindqvist; James E Vince
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 2.  Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.

Authors:  Martin Wolley; Meg Jardine; Colin A Hutchison
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-05       Impact factor: 8.237

3.  The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.

Authors:  Arwa Younis; Dana Eskenazi; Ronen Goldkorn; Jonathan Leor; Nili Naftali-Shani; Enrique Z Fisman; Alexander Tenenbaum; Ilan Goldenberg; Robert Klempfner
Journal:  Cardiovasc Diabetol       Date:  2017-05-22       Impact factor: 9.951

Review 4.  Novel Antiatherosclerotic Therapies.

Authors:  Peter Libby; Brendan M Everett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 5.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

6.  Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction.

Authors:  Hendrik B Sager; Timo Heidt; Maarten Hulsmans; Partha Dutta; Gabriel Courties; Matthew Sebas; Gregory R Wojtkiewicz; Benoit Tricot; Yoshiko Iwamoto; Yuan Sun; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf
Journal:  Circulation       Date:  2015-09-10       Impact factor: 29.690

7.  TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.

Authors:  Tao Yang; Linnan Zhu; Yanhua Zhai; Qingjie Zhao; Jianxia Peng; Hongbing Zhang; Zhongzhou Yang; Lianfeng Zhang; Wenjun Ding; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2015-05-25       Impact factor: 11.530

Review 8.  Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation.

Authors:  I Barchetta; F A Cimini; G Ciccarelli; M G Baroni; M G Cavallo
Journal:  J Endocrinol Invest       Date:  2019-05-09       Impact factor: 4.256

Review 9.  The intersection of cell death and inflammasome activation.

Authors:  James E Vince; John Silke
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

10.  Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.

Authors:  Marit Westerterp; Panagiotis Fotakis; Mireille Ouimet; Andrea E Bochem; Hanrui Zhang; Matthew M Molusky; Wei Wang; Sandra Abramowicz; Sacha la Bastide-van Gemert; Nan Wang; Carrie L Welch; Muredach P Reilly; Erik S Stroes; Kathryn J Moore; Alan R Tall
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.